首页 | 本学科首页   官方微博 | 高级检索  
     

1例帕罗西汀与脑蛋白水解物联用发生相互作用病例分析
引用本文:胡永梅. 1例帕罗西汀与脑蛋白水解物联用发生相互作用病例分析[J]. 中国药房, 2011, 0(26): 2488-2490
作者姓名:胡永梅
作者单位:山西运城市中心医院;
摘    要:目的:阐明临床药师在临床治疗中发挥作用的有效切入点。方法:临床药师通过临床查房,发现帕罗西汀与脑蛋白水解物联用存在潜在的相互作用,通过查阅大量资料,获知帕罗西汀为细胞色素P450酶(CYP)2D6抑制剂,影响了脑蛋白水解物在体内的代谢,引起不良的相互作用。结果:临床药师提出合理的治疗方案,医师采纳并实施方案后,患者康复出院。结论:临床药师在临床治疗的切入点可以是治疗中出现的不良反应,也可以是患者的用药依从性等其他方面。

关 键 词:临床药师  帕罗西汀  脑蛋白水解物  相互作用

Analysis of 1 Case of Drug Interaction of Paroxetine and Brain Protein Hydrolyzate
HU Yong-mei. Analysis of 1 Case of Drug Interaction of Paroxetine and Brain Protein Hydrolyzate[J]. China Pharmacy, 2011, 0(26): 2488-2490
Authors:HU Yong-mei
Affiliation:HU Yong-mei(Shanxi Yuncheng Central Hospital,Yuncheng 044000,China)
Abstract:OBJECTIVE:To clarify the effective breakthrough point of roles which clinical pharmacists play in the clinical treatment. METHODS: Through clinical rounds, clinical pharmacists found that the combination between paroxetine and brain protein hydrolyzate may cause disruption. By searching a large number of documents, clinical pharmacists were informed that paroxetine was the P450 liver enzyme(CYP)2D6 inhibitors, which affected the brain protein hydrolyzate metabolism in vivo, causing adverse interaction. RESU...
Keywords:Clinical pharmacist  Paroxetine  Brain protein hydrolyzate  Interaction  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号